PRECY KUMAR: Open Payments
NPI 1619023470 · PEMBROKE PINES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,574 in 68 payments from 15 companies in 2025. Trend: 2023 $1,098 · 2024 $1,419 · 2025 $1,574
Food & beverage: $1,574
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 14 | $358 |
| AstraZeneca Pharmaceuticals LP | 11 | $269 |
| GlaxoSmithKline, LLC. | 14 | $230 |
| Regeneron Healthcare Solutions, Inc. | 9 | $165 |
| Genentech, Inc. | 1 | $139 |
| Ionis Pharmaceuticals, Inc. | 7 | $135 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| Organon LLC | 2 | $46 |
| BioCryst US Sales Co., LLC | 2 | $45 |
| Grifols USA, LLC | 1 | $27 |
Products named: DUPIXENT, TEZSPIRE, Xolair, TRELEGY ELLIPTA, DAWNZERA, NUCALA, ORLADEYO, FASENRA.
Industry payments across FL — which companies pay providers there.
